Cash flows from operating activities | |
Net loss | -6.27M |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Stock payable for acquired research and development | |
Stock issued for acquired research and development | |
Stock issued for services | |
Stock issued for debt in excess of principal | |
Amortization of discount on notes payable due to warrants and beneficial conversion feature | |
Gain on extinguishment of debt | |
Depreciation | |
Amortization of debt financing costs | |
Option expense | 485.96K |
Loss on derivative instruments | |
Loss on disposal of assets | 0 |
Changes in: | |
Other current assets | 356.76K |
Accounts payable - third parties and related parties | 278.56K |
Accrued expenses | 91.48K |
Net cash used in operating activities | |
Cash flows from investing activities | |
Purchase of property & equipment | -1.22K |
Net cash used in investing activities | |
Cash flows from financing activities | |
Common stock and warrants sold for cash, net of offering costs | 276.91K |
Common stock repurchased and canceled | |
Proceeds from exercise of warrants and options | |
Proceeds from debt | |
Repayments on notes payable | -148.34K |
Net cash provided by financing activities | |
Net change in cash and cash equivalents | -6.77M |
Cash and cash equivalents at beginning of period | 12.58M |
Cash and cash equivalents at end of period | 5.81M |
Cash paid for: | |
Income tax | |
Interest | 2.35K |
NON-CASH TRANSACTIONS | |
Issuance of common stock to Sportan shareholders | |
Issuance of common stock for accrued interest | |
Issuance of warrants to placement agent | |
Conversion of notes payable to common stock | |
Conversion of accrued liabilities to common stock | |
Conversion of accounts payable to note payable | |
Discount on convertible notes relating to: | |
Warrants | |
Beneficial conversion feature | |
Stock attached to notes | |
Fair value of derivative instrument | |
Derivative reclassified to equity | |
Unpaid additions to property and equipment |